MARLA DIXON: Open Payments
NPI 1598814469 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,765 in 77 payments from 12 companies in 2025. Trend: 2023 $1,727 · 2024 $1,350 · 2025 $1,765
Food & beverage: $1,681Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $392 |
| Ardelyx, Inc. | 8 | $368 |
| ABBVIE INC. | 11 | $340 |
| Madrigal Pharmaceuticals | 4 | $186 |
| Aimmune Therapeutics, Inc. | 17 | $167 |
| Phathom Pharmaceuticals, Inc. | 11 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Gilead Sciences, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $30 |
| Boston Scientific Corporation | 1 | $19 |
Products named: TREMFYA, IBSRELA, CREON, REZDIFFRA, ZENPEP, SKYRIZI, VOQUEZNA, ENTYVIO.
Industry payments across GA — which companies pay providers there.
